NovelStem International Corp. (NSTM)
0.0095
0.00 (0.00%)
USD |
OTCM |
Aug 21, 16:00
NovelStem International Total Liabilities (Quarterly) : 2.097M for June 30, 2026
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 2.097M |
| March 31, 2026 | 2.048M |
| December 31, 2025 | 2.157M |
| September 30, 2025 | 2.067M |
| June 30, 2025 | 1.990M |
| March 31, 2025 | 5.493M |
| December 31, 2024 | 5.304M |
| September 30, 2024 | 5.189M |
| June 30, 2024 | 4.874M |
| March 31, 2024 | 4.642M |
| December 31, 2023 | 4.206M |
| September 30, 2023 | 4.034M |
| June 30, 2023 | 3.038M |
| March 31, 2023 | 0.5237M |
| December 31, 2022 | 0.3533M |
| September 30, 2022 | 0.2938M |
| June 30, 2022 | |
| March 31, 2022 | |
| December 31, 2021 | |
| September 30, 2021 | |
| June 30, 2021 | |
| March 31, 2021 | |
| December 31, 2020 | |
| September 30, 2020 | |
| June 30, 2020 |
| Date | Value |
|---|---|
| March 31, 2020 | |
| December 31, 2019 | |
| September 30, 2019 | |
| June 30, 2019 | |
| March 31, 2019 | |
| December 31, 2018 | |
| September 30, 2018 | |
| June 30, 2018 | |
| March 31, 2018 | |
| December 31, 2017 | |
| September 30, 2017 | |
| June 30, 2017 | |
| March 31, 2017 | |
| December 31, 2016 | |
| September 30, 2016 | |
| June 30, 2016 | |
| March 31, 2016 | |
| December 31, 2015 | |
| September 30, 2015 | |
| June 30, 2015 | |
| March 31, 2015 | |
| December 31, 2014 | |
| September 30, 2014 | |
| June 30, 2014 | |
| March 31, 2014 |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Brainstorm Cell Therapeutics, Inc. | 12.38M |
| Summit Therapeutics, Inc. | 122.20M |
| Kezar Life Sciences, Inc. | 2.762M |
| Protara Therapeutics, Inc. | 14.78M |
| Clene, Inc. | 47.82M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 0.0647M |
| Shareholders Equity (Quarterly) | -2.032M |
| Debt to Equity Ratio | -0.8748 |
| Current Ratio | 0.0309 |
| Net Debt Paydown Yield | 88.07% |